1. CTIM-30. PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS. (12th November 2021) Authors: Brastianos, Priscilla; Kim, Albert; Giobbie-Hurder, Anita; Lee, Eudocia Quant; Wang, Nancy; Eichler, April; Chukwueke, Ugonma; Forst, Deborah; Arrillaga-Romany, Isabel; Dietrich, Jorg; Lou, Kevin; Larson, Juliana; Mora, Joana; Nayyar, Naema; Loeffler, Jay; Oh, Kevin; Shih, Helen; Curry, William; ... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗